Time-dependent DNA condensation induced by amyloid β-peptide

Biophysical Journal

Volumn 92, Issue 1, 2007, Pages 185-191

  Yu, Haijia ^a   Ren, Jinsong ^a   Qu, Xiaogang ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; COPPER ION; ZINC ION;

ALZHEIMER DISEASE; ARTICLE; CHROMATIN CONDENSATION; DNA CONFORMATION; HIPPOCAMPUS; NERVE CELL; NERVE DEGENERATION; REACTION TIME;

EID: 33846005463     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.106.093559     Document Type: Article

References (47)

1. Masters, C. L., G. Simms, N. A. Weinman, G. Multhaup, B. L. McDonald, and K. Beyreuther. 1985. Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:4245-4249.
2. Selkoe, D. J. 1996. Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:18295-18298.
3. Soto, C., and E. M. Castano. 1996. The conformation of Alzheimer's β peptide determines the rate of amyloid formation and its resistance to proteolysis. Biochem. J. 314:701-707.
4. Sisodia, S. S. 1992. β-Amyloid precursor protein cleavage by a membrane bound protease. Proc. Natl. Acad. Sci. USA. 89:6075-6079.
5. Mori, H., K. Takio, M. Ogawara, and D. J. Selkoe. 1992. Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J. Biol. Chem. 267:17062-17086.
6. Selkoe, D. J. 2004. Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases. Nat. Cell Biol. 6:1054-1061.
7. Pike, C. J., D. Burdick, A. J. Walencewicz, C. G. Glabe, and C. W. Cotman. 1993. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1676-l 687.
8. Pike, C. J., A. J. Walencewicz, J. Kosmoski, D. H. Cribbs, C. G. Glabe, and C. W. Cotman. 1995. Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64:253-265.
9. Lorenzo, A., and B. A. Yankner. 1994. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA. 91:12243-122 47.
10. Lambert, M. P., A. K. Barlow, B. A. Chromy, C. Edwards, R. Freed, M. Liosatos, T. E. Morgan, I. Rozovsky, B. Trommer, K. L. Viola, P. Wals, C. Zhang, C. E. Finch, G. A. Krafft, and W. L. Klein. 1998. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA. 95:6448-6453.
11. Kim, H. J., S. C. Chae, D. K. Lee, B. Chromy, S. C. Lee, Y. C. Park, W. L. Klein, G. A. Krafft, and S. T. Hong. 2003. Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein. FASEB J. 17:118-120.
12. Hilbich, C., B. Kisters-Woike, J. Reed, C. L. Masters, and K. Beyreuther. 1991. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J. Mol. Biol. 218:149-163.
13. Bush, A. I., W. H. Pettingell, G. Multhaup, M. D. Paradis, J. P. Vonsattel, J. F. Gusella, K. Beyreuther, C. L. Masters, and R. E. Tanzi. Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 265:1464-1467.
14. Yang, D. S., C. M. Yip, T. H. Huang, A. Chakrabartty, and P. E. Fraser. 1994. Manipulating the Amyloid-β aggregation pathway with chemical chaperones. J. Biol. Chem. 274:32970-32974.
15. Zeng, H., Q. Chen, and B. Zhao. 2004. Genistein ameliorates β-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis. Free Radical Bio. Med. 36:180-188.
16. Pillot, T., B. Drouet, S. Queille, C. Labeur, J. Vandekerckhove, M. Rosseneu, M. Pincxon-Raymond, and J. Chambaz. 1999. The nonfibrillar amyloid β-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain. J. Neurochem. 73:1626-1634.
17. Blanc, E. M., M. Toborek, R. J. Mark, B. Hennig, and M. P. Mattson. 1997. Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J. Neurochem. 68:1870-1881.
18. Anitha, S., K. S. R. Jagannatha, K. S. Latha, and M. A. Viswamitra. 2002. First evidence to show the topological change of DNA from B-DNA to Z-DNA conformation in the hippocampus of Alzheimer's brain. NeuroMol. Med. 2:289-298.
19. Hegde, M. L., S. Anitha, and K. S. Latha. 2003. First evidence for helical transitions in supercoiled DNA by amyloid beta peptide(1-42) and aluminum-A new insight in understanding Alzheimer's disease. J. Mol. Neurosci. 22:19-31.
20. Childs, A. C., D. J. Mehta, and E. W. Gerner. 2003. Polyamine-dependent gene expression. Cell. Mol. Life Sci. 60:1394-1406.
21. Arents, G., and E. N. Moudrianakis. 1993. Topography of the histone octamer surface: repeating structural motifs utilized in the docking of nucleosomal DNA. Proc. Natl. Acad. Sci. USA. 90:10489-10493.
22. Yoshiike, Y., K. Tanemura, O. Murayama, T. Akagi, M. Murayama, S. Sato, X. Sun, N. Tanaka, and A. Takashima. 2001. New insights on how metals disrupt amyloid β-aggregation and their effects on amyloid-β cytotoxicity. J. Biol. Chem. 276:32293-32299.
23. Li, X., Y. Peng, and X. Qu. 2006. Carbon nanotubes selective destabilization of duplex and triplex DNA and inducing B-A transition in solution. Nucleic Acids Res. 34:3670-3676.
24. Zhang, H., H. Yu, J. Ren, and X. Qu. 2006. PolydA and polyrA selfstructured by A auropium and amino acid complex. FEBS Lett. 580:3726-3730.
25. Zhang, H., H. Yu, J. Ren, and X. Qu. 2006. Reversible B/Z-DNA transition under the low salt condition and non-B-form PolydApolydT selectivity by a cubane-like Europium-L-aspartic acid complex. Biophys. J. 90:3203-3207.
26. Anitha, S., and K. S. R. Jagannatha. 2003. Challenges and excitements in understanding of abeta peptides and aluminium induce helical transitions in supercoiled DNA and POL. J. Neurochem. 87:93-93 (Suppl.).
27. Chittimalla, C., L. Zammut-Italiano, G. Zuber, and J. P. Behr. 2005. Monomolecular DNA nanoparticles for intravenous Delivery of genes. J. Am. Chem. Soc. 127:11436-11441.
28. Trubetskoy, V. S., V. G. Budker, L. J. Hanson, P. M. Slattum, J. A. Wolff, and J. E. Hagstrom. 1998. Self- assembly of DNA-polymer complexes using template polymerization. Nucleic Acids Res. 26:4178-4185.
29. Krishnamoorthy, G., G. Duportail, and Y. Mély. 2002. Structure and dynamics of condensed DNA probed by 1,1′-(4,4,8,8-Tetramethyl-4,8- diazaundecamethylene)bis[4-[[3-methylbenz- 1,3-oxazol- 2-yl]methylidine]-1,4- dihydroquinolinium] tetraiodide fluorescence. Biochemistry. 41:15277-15287.
30. Xu, Y. H., and F. C. Szoka. 1996. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry. 35:5616-5623.
31. McKenzie, D. L., K. Y. Kwok, and K. G. Rice. 2000. A potent new class of reductively activated peptide gene delivery agents. J. Biol. Chem. 275:9970-9977.
32. Thual, C., A. A. Komar, L. Bousset, E. Fernandez-Bellot, C. Cullin, and R. Melki. Structural characterization of Saccharomyces cerevisiae prion-like protein Ure2. J. Biol. Chem. 274:13666-13614.
33. Roy, K. B., T. Antony, A. Saxena, and H. B. Bohidar. 1999. Ethanol-induced condensation of calf thymus DNA studied by laser light scattering. J. Phys. Chem. B. 103:5117-5121.
34. De Felice, F. G., J. C. Houzel, J. Garcia-Abreu, P. R. F. Louzada, R. C. Afonso, M. N. L. Meirelles, R. Lent, V. M. Neto, and S. T. Ferreira. 2001. Inhibition of Alzheimer's disease b-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy. FASEB J. 15:1297-1299.
35. Bodles, A. M., D. J. S. Guthrie, P. Harriott, P. Campbell, and G. B. Irvine. 2000. Toxicity of non-Ab component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of b-sheet structure and fibrils. Eur. J. Biochem. 267:2186-2194.
36. 2+ inhibits the aggregation of amyloid β-peptide(1-42) in vitro. Angew. Chem. Int. Ed. Engl. 40:2274-2277.
37. Nandi, P. K., and E. Leclerc. 1999. Polymerization of murine recombinant prion protein in nucleic acid solution. Arch. Virol. 144:1751-1763.
38. Nandi, P. K., and P. Y. Sizaret. 2001. Murine recombinant prion protein induces ordered aggregation of linear nucleic acids to condensed globular structures. Arch. Virol. 146:327-345.
39. Church, G. M., J. L. Sussman, and S. Kim. 1977. Secondary structural complementarity between DNA and proteins. Proc. Natl. Acad. Sci. USA. 74:1458-1462.
40. Ginsberg, S. D., P. B. Crino, S. E. Hemby, J. A. Weingarten, V. M. Lee, J. M. Eberwine, and J. Q. Trojanowski. 1999. Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques. Ann. Neurol. 45:174-181.
41. Ginsberg, S. D., J. E. Galvin, T. Chiu, V. M. Lee, E. Masliah, and J. Q. Trojanowski. 1998. RNA sequestration to pathological lesions of neurodegenerative diseases. Acta Neuropathol. (Berl.). 96:487-494.
42. Ylera, F., R. Lurz, V. A. Erdmann, and J. P. Furste. 2002. Selection of RNA aptamers to the Alzheimer's disease amyloid peptide. Biochem. Biophys. Res. Commun. 290:1583-1588.
43. Kienlen-Campard, P., S. Miolet, B. Tasiaux, and J. N. Octave. 2002. Intracellular amyloid-β1-42, but not extracellular soluble amyloid-β peptides, induces neuronal apoptosis. J. Biol. Chem. 277:15666-15670.
44. Gouras, G. K., J. Tsai, J. Naslund, B. Vincent, M. Edgar, F. Checler, J. P. Greenfield, V. Haroutunian, J. D. Buxbaum, H. Xu, P. Greengard, and N. R. Relkin. 2000. Intraneuronal Aβ42 accumulation in human brain. Am. J. Pathol. 156:15-20.
45. Lyras, L., N. J. Cairns, A. Jenner, P. Jenner, and B. Halliwell. 1997. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68:2061-2069.
46. Crapper, D. R., S. Quittkat, and U. De. Boni. 1979. Altered chromatin conformation in Alzheimer's disease. Brain. 102:483-495.
47. Golabek, A. A., C. Soto, T. Vogel, and T. Wisniewski. 1996. The interaction between Apolipoprotein E and Alzheimer's amyloid β-peptide is dependent on β-peptide conformation. J. Biol. Chem. 271:10602-10606.